Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.07.008Source: DataRank Database

Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease is a research paper published in Transplantation and Cellular Therapy (2022). On theSindex it has a DataRank of 0. It has been cited 30 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access30 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.70)OA: hybridTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Brittany Paige DePriest,Maedeh Vakili Saatloo ORCID,Hua Jiang ORCID,Denggang Fu ORCID,Sophie Paczesny ORCID

Live enrichment

PubMed:35830932 PMC:PMC9547856 OpenAlex:https://openalex.org/W4285009263

National Institutes of Health

Grant: 10,571,478 B2

National Institutes of Health

Grant: R21 HL139934

NHLBI

Grant: R01 HL158096

NCI

Grant: R01 CA168814

NCI

Grant: R01 CA264921

FWCI

3.70

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.jtct.2022.07.008

HYBRIDhttps://doi.org/10.1016/j.jtct.2022.07.008

publisherhttps://doi.org/10.1016/j.jtct.2022.07.008

publisherhttps://api.elsevier.com/content/article/PII:S2666636722014701?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666636722014701?httpAccept=text/plain

Fields of Study

Hematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia researchAcute Myeloid Leukemia ResearchMedicineBiomarkersConsensusGraft vs Host DiseaseHumansNational Institutes of Health (U.S.)United States

MeSH Terms

Graft vs Host DiseaseHumansNational Institutes of Health (U.S.)United StatesBiomarkersHematopoietic Stem Cell TransplantationConsensus

Keywords

BiomarkerMedicineClinical trialGraft-versus-host diseaseDiseaseHematopoietic stem cell transplantationIntensive care medicineDrug developmentBiomarker discoveryHematopoietic cellTransplantationConfusionFood and drug administrationBioinformaticsInternal medicineDrugHaematopoiesisStem cellPsychologyBiologyPsychiatry

Sustainable Development Goals

SDG 0: Good health and well-being

Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease

FAIR Checklist

Authors (6)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)